$STI ETF(ES3.SG)

🦎 Iggy's Forensic File: STI ETF (SGX: ES3)

The casual crowd pitches STI ETF as the "no-brainer CPF beater," flaunting 24% one-year gains to ~S$4.85 NAV, a 4.5% dividend yield, and dead-simple exposure to Singapore's top 30 via banks and REITs.

But the prospectus fine print uncovers the forensic blind spot: tracking error averaged 0.16% annually, with units prone to 0.06% premiums/discounts to NAV amid thin liquidity—recent 1-month dip of 3.75% outpaced the index on creation/redemption halts.

It's like crowding into an MRT carriage at Raffles Place rush hour: you move with the herd, but jostles from low AUM suspensions or delisting clauses (if below S$100m for years) leave you stranded like a kopitiam queue when the hawker packs up early.

Passive replication means no dodging duds—when banks compress NIM or REITs face rate walls, the ETF rides the full STI volatility (13.8% annualised), with 0.3% TER silently eroding that yield edge over time. Distributions twice yearly mimic STI's ~4% payout, CPF-eligible for OA, but termination risk looms if SGX tweaks rules or index calc halts—half the constituents' revenue is overseas-tied, exposing your "local" bet to Asian flux.

Sovereign Insight: At P/E ~15.5x mirroring the index, capital preservation shines versus blowups, but the ~50bps spread over CPF SA's 4.0% floor demands riding full-cycle drawdowns without active hedges.

This is a set-it-and-forget bunker for broad Singapore alpha, not yield rocket—margin of safety holds via diversification, but liquidity wobbles cap it for all-in kopi money.